CAS: 31181-88-1; 5-Fluoropicolinaldehyde

相似化合物

107504-08-5 327056-62-2 802325-29-7

上下游产品

5-氟-2-吡啶羧酸 5-Fluoropicolinic Acid 107504-08-5
5-氟吡啶-2-甲酸甲酯 Methyl 5-Fluoropyridine-2-Carboxylate 107504-07-4
2-氰基-5-氟吡啶 5-Fluoropicolinonitrile 327056-62-2
5-氟-2-羟基甲基吡啶 (5-Fluoropyridin-2-yl)Methanol 802325-29-7
5-氟-2-吡啶羧酸乙酯 Ethyl 5-Fluoro-2-Pyridinecarboxylate 148541-70-2

5-氟吡啶-2-甲酸甲酯置于二异丁基氢化铝,戴斯-马丁氧化剂体系中,用 二氯甲烷 作为反应溶剂,化学反应 2.0H,反应生成 5-氟吡啶-2-醛
参考文献: Novel Oxalyl Piperazines Active Against The Hepatitis B Virus (Hbv)[fr] Nouvelles Oxalyl Pipérazines Actives Contre Le Virus De L'Hépatite B (Vhb)
标题: Novel Oxalyl Piperazines Active Against The Hepatitis B Virus (Hbv)[fr] Nouvelles Oxalyl Pipérazines Actives Contre Le Virus De L'Hépatite B (Vhb)
摘要:本发明一般涉及新型抗病毒药剂.具体地,本发明涉及能够抑制乙型肝炎病毒(hbv)编码的蛋白质或干扰hbv复制周期功能的化合物,包含这种化合物的组合物,抑制hbv病毒复制的方法,治疗或预防hbv感染的方法,以及制备这些化合物的工艺和中间体.

专利信息

专利号:CN-113603687-A
优先权日:2021-08-02
标 题:A new method for the synthesis of cyano-substituted imidazo[1,5-a]pyridines

专利号:US-8138188-B2
优先权日:2006-02-23
标题 :Melanocortin type 4 receptor agonist piperidinoylpyrrolidines
发明人：ANDREWS MARK DAVID; BROWN ALAN DANIEL; LANSDELL MARK IAN; SUMMERHILL NICHOLAS WILLIAM
权利人:ANDREWS MARK DAVID; BROWN ALAN DANIEL; LANSDELL MARK IAN; SUMMERHILL NICHOLAS WILLIAM; PFIZER
摘要:The present invention relates to a class of melanocortin MCR4 agonists of general formula (I) n nwherein the variables and substituents are as defined herein and especially to selective MCR4 agonist compounds, to their use in medicine, particularly in the treatment of sexual dysfunction and obesity, to intermediates useful in their synthesis and to compositions containing them.